Health Industry Impact Report Q1, 2025: 55% of Healthcare Organisations Delay Mental Health Investments Due to Tariff-Driven Supply Chain Disruptions

Featuring UnitedHealth Group, Johnson & Johnson, Roche Holding, Pfizer, Abbott Laboratories, and Many More


Dublin, May 07, 2025 (GLOBE NEWSWIRE) -- The "Health Impact Report: All Industries Edition, Q1 2025" has been added to ResearchAndMarkets.com's offering.

This cross-sectoral analysis reveals how mental health has emerged as a critical health and safety concern for businesses across the healthcare value chain, with nearly a quarter of employees (23%) taking sick leave due to mental health issues. The research examines how this trend affects operational continuity, workforce productivity, and corporate culture throughout the healthcare sector, requiring robust materiality assessment processes that consider both financial materiality (through absenteeism costs and productivity impacts) and impact materiality (through employee well-being and community health outcomes).

The report additionally reveals how tariff-driven supply chain disruptions have complicated wellbeing initiatives for 55% of healthcare organisations particularly affecting investments in mental health technologies and employee support programmes.

Call to Action: Health sector organisations should develop regionally diversified supply networks and implement flexible wellbeing strategies that can adapt to trade policy fluctuations ensuring mental health commitments remain achievable despite economic pressures.

The report highlights that the recognition of mental health conditions is underrepresented in SDG #3 indicators, creating potential blind spots in global health governance frameworks. This gap suggests opportunities for healthcare organisations to lead in establishing more comprehensive approaches to mental health integration within sustainability reporting and objectives. Companies implementing sophisticated mental health metrics are establishing new standards for ESG disclosure, which may inform future regulatory frameworks under initiatives such as the CSRD.

This analysis explores how leading companies are implementing three-pillar approaches to mental health, focusing on prevention, promotion and support throughout their operations. These comprehensive strategies recognise mental health as an interconnected challenge that requires interventions at individual, organisational, and systemic levels. Organisations implementing these approaches are demonstrating enhanced awareness of double materiality considerations, where mental health initiatives create both business value and broader societal benefits.

The report examines how AI technologies are being integrated into mental health support systems, with advanced platforms breaking down barriers to care by providing tailored solutions that consider cultural context, language preferences and unique experiences of diverse populations. These technological innovations enable more personalised resources while generating valuable data insights to inform future mental health initiatives across the healthcare sector.

Looking toward future collaboration landscapes, the report identifies how cross-sector partnerships are building more sustainable healthcare systems through integrated approaches to mental health. These collaborations leverage diverse expertise, resources, and distribution channels to enhance the accessibility and effectiveness of mental health services. Organisations participating in these collaborative initiatives are demonstrating enhanced strategic vision while potentially securing advantages in talent attraction, retention and engagement across increasingly competitive healthcare labour markets.

Analyst Insights

In this latest quarterly review of corporate sustainability impacts risks and opportunities, the analyst finds that mental health has emerged as a critical health and safety concern for businesses across the healthcare value chain. The report highlights that nearly a quarter of employees (23%) have taken sick leave due to mental health issues while recognition of mental health conditions lacks sufficient representation in SDG#3 indicators.

The analysis also examines how tariff-driven supply chain disruptions are creating additional pressures for healthcare organisations with 55% reporting that trade uncertainties have delayed investments in employee wellbeing programmes and mental health technologies. Companies implementing regionally diversified supply networks and developing flexible wellbeing strategies that anticipate trade policy shifts are demonstrating enhanced resilience while maintaining progress on mental health commitments despite economic constraints.

Key Topics Covered

1. Nature and Climate Risks
2. Value Chain: Upstream
3. Value Chain: Downstream
4. Planet-Environmental Impacts
5. People-Social and Governance Impacts
6. UN Sustainable Development Goals
7. Technology
8. Finance
9. Policy
10. Calendar of Events
11. Risks Profile
12. Industry Sustainability Highlights

Companies Featured

  • UnitedHealth Group
  • Johnson & Johnson
  • Roche Holding
  • Pfizer
  • Abbott Laboratories
  • Novartis
  • Merck & Co.
  • AbbVie
  • AstraZeneca
  • Medtronic plc
  • Novo Nordisk
  • Amgen
  • Sanofi
  • GE HealthCare Technologies
  • Elevance Health
  • Eli Lilly
  • Stryker Corporation
  • CVS Health
  • Cigna
  • Boston Scientific
  • HCA Healthcare
  • Becton, Dickinson and Company
  • Intuitive Surgical
  • Humana
  • Takeda Pharmaceutical
  • Siemens Healthineers
  • IQVIA Holdings
  • Edwards Lifesciences
  • Centene
  • Danaher Corporation
  • Cerner
  • Zimmer Biomet
  • Laboratory Corporation of America
  • Olympus
  • Koninklijke Philips N.V.
  • Molina Healthcare
  • Dr. Sulaiman Al Habib Medical Services Group
  • Quest Diagnostics
  • Tata Medical and Diagnostics
  • Techint Group
  • Wuxi AppTec
  • Bangkok Dusit Medical Services
  • Universal Health Services
  • Al Faisaliah Medical Systems
  • Apollo Hospitals Enterprise
  • Aspen Pharmacare
  • DaVita
  • Tenet Healthcare
  • Biocon
  • Aspen Pharmacare Holdings
  • Hypermarcas
  • Shanghai Pharmaceuticals
  • Hikma Pharmaceuticals
  • Sun Pharmaceutical
  • Vertex Pharmaceuticals
  • Hindustan Medical Devices
  • Ping An Healthcare and Technology
  • Auna
  • Nihon Kohden

For more information about this report visit https://www.researchandmarkets.com/r/h4atvj

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

 

Contact Data

Recommended Reading